Home Other Building Blocks 10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine

10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine

CAS No.:
84-97-9
Catalog Number:
AG00G75R
Molecular Formula:
Molecular Weight:
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG00G75R
Chemical Name:
10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine
CAS Number:
84-97-9
MDL Number:
MFCD00156243
IUPAC Name:
10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine
InChI:
InChI=1S/C20H25N3S/c1-21-13-15-22(16-14-21)11-6-12-23-17-7-2-4-9-19(17)24-20-10-5-3-8-18(20)23/h2-5,7-10H,6,11-16H2,1H3
InChI Key:
WEYVCQFUGFRXOM-UHFFFAOYSA-N
EC Number:
201-578-9
UNII:
8915147A2B
NSC Number:
638694
Properties
Complexity:
374  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
339.177g/mol
Formal Charge:
0
Heavy Atom Count:
24  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
339.501g/mol
Monoisotopic Mass:
339.177g/mol
Rotatable Bond Count:
4  
Topological Polar Surface Area:
35A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.1  
Literature
Title Journal
Attentional and emotional functioning in schizophrenia patients treated with conventional and atypical antipsychotic drugs. Medical science monitor : international medical journal of experimental and clinical research 20120101
Revisiting thyroid hormones in schizophrenia. Journal of thyroid research 20120101
Soluble cytokine receptors (sIL-2Rα, sIL-2Rβ) induce subunit-specific behavioral responses and accumulate in the cerebral cortex and basal forebrain. PloS one 20120101
Auditing clinical outcomes after introducing off-licence prescribing of atypical antipsychotic melperone for patients with treatment refractory schizophrenia. TheScientificWorldJournal 20120101
Some dopaminergic genes polymorphisms are not associated with response to antipsychotic drugs in schizophrenic patients. Pharmacological reports : PR 20120101
Management of marked liver enzyme increase during olanzapine treatment: a case report and review of the literature. Psychiatria Danubina 20110901
The effect of psychotropic drugs on cytochrome P450 2D (CYP2D) in rat brain. European journal of pharmacology 20110125
Effect of neuroleptics on cytochrome P450 2C11 (CYP2C11) in rat liver. Pharmacological reports : PR 20110101
Main contribution of the cytochrome P450 isoenzyme 1A2 (CYP1A2) to N-demethylation and 5-sulfoxidation of the phenothiazine neuroleptic chlorpromazine in human liver--A comparison with other phenothiazines. Biochemical pharmacology 20101015
The role of CYP2D6 and TaqI A polymorphisms in malignant neuroleptic syndrome: two case reports with three episodes. Psychiatria Danubina 20100301
[Perazine in the treatment of psychotic disorders--research review]. Psychiatria polska 20100101
Increased D-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study. Journal of neural transmission (Vienna, Austria : 1996) 20091201
Perazine elevates clozapine serum levels by inhibiting hepatic metabolism. Progress in neuro-psychopharmacology & biological psychiatry 20090801
Validation of derivative spectrophotometry method for determination of active ingredients from neuroleptics in pharmaceutical preparations. Acta poloniae pharmaceutica 20090101
Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects. BMC psychiatry 20090101
[Drug-induced agranulocytosis--case reports and literature review]. Przeglad lekarski 20090101
Perazine at therapeutic drug concentrations inhibits human cytochrome P450 isoenzyme 1A2 (CYP1A2) and caffeine metabolism--an in vitro study. Pharmacological reports : PR 20090101
Spectroscopic and electrochemical analysis of psychotropic drugs. Indian journal of pharmaceutical sciences 20090101
Amisulpride plus valproate vs haloperidol plus valproate in the treatment of acute mania of bipolar I patients: a multicenter, open-label, randomized, comparative trial. Neuropsychiatric disease and treatment 20080601
Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment. European journal of clinical pharmacology 20080201
Typical and atypical antipsychotics--the misleading dichotomy. Results from the Working Group 'Drugs in Psychiatry' (AGATE). Neuropsychobiology 20080101
The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913). BMC psychiatry 20080101
[Antipsychotics in clinical practice. Treatment of the first schizophrenic episode]. Psychiatria polska 20080101
[Application of liquid chromatography coupled with mass spectrometry (LC/MS) to determine antidepressants in blood samples]. Archiwum medycyny sadowej i kryminologii 20080101
Simple and simultaneous determination for 12 phenothiazines in human serum by reversed-phase high-performance liquid chromatography. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070701
[Ischemic colitis without atherosclerosis?]. Deutsche medizinische Wochenschrift (1946) 20070330
Perazine and carbamazepine in comparison to olanzapine in schizophrenia. Neuropsychobiology 20070101
The activity of cytochrome P450 CYP2B in rat liver during neuroleptic treatment. Pharmacological reports : PR 20070101
Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20061020
Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia. PLoS medicine 20060801
[Trazodone for the treatment of behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease: a retrospective study focused on the aggression and negativism in caregiving situations]. No to shinkei = Brain and nerve 20060601
Perazine for schizophrenia. The Cochrane database of systematic reviews 20060419
Effect of chronic treatment with perazine on lipopolysaccharide-induced interleukin-1 beta levels in the rat brain. Naunyn-Schmiedeberg's archives of pharmacology 20060401
Characterization of human cytochrome p450 enzymes involved in the metabolism of the piperidine-type phenothiazine neuroleptic thioridazine. Drug metabolism and disposition: the biological fate of chemicals 20060301
Automated analysis of quetiapine and other antipsychotic drugs in human blood by high performance-liquid chromatography with column-switching and spectrophotometric detection. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060118
Increased serum interleukin-1beta and interleukin-6 in elderly, chronic schizophrenic patients on stable antipsychotic medication. Neuropsychiatric disease and treatment 20050601
Inhibition of rat liver CYP2D in vitro and after 1-day and long-term exposure to neuroleptics in vivo-possible involvement of different mechanisms. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20050101
Acute psychosis with a mediastinal carcinoma metastasis. Medical science monitor : international medical journal of experimental and clinical research 20050101
Direct effects of neuroleptics on the activity of CYP2A in the liver of rats. Pharmacological reports : PR 20050101
Interactions between neuroleptics and CYP2C6 in rat liver--in vitro and ex vivo study. Pharmacological reports : PR 20050101
Analysis of phenothiazines in human body fluids using disk solid-phase extraction and liquid chromatography. Journal of AOAC International 20050101
Schizophrenia. Clinical evidence 20041201
Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds--implications for pharmacokinetics of selected substrates. The Journal of pharmacy and pharmacology 20040801
Halogenation of drugs enhances membrane binding and permeation. Chembiochem : a European journal of chemical biology 20040503
The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20040501
The AMUP study for drug surveillance in psychiatry - a summary of inpatient data. Pharmacopsychiatry 20040301
Blood dyscrasias induced by psychotropic drugs. Pharmacopsychiatry 20040301
Schizophrenia. Clinical evidence 20031201
Screening, library-assisted identification and validated quantification of fifteen neuroleptics and three of their metabolites in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization. Journal of mass spectrometry : JMS 20030301
Mechanisms of cellular distribution of psychotropic drugs. Significance for drug action and interactions. Progress in neuro-psychopharmacology & biological psychiatry 20030201
Which neuroleptic would psychiatrists take for themselves or their relatives? European psychiatry : the journal of the Association of European Psychiatrists 20030201
Antipsychotic efficacy of the antidepressant trimipramine: a randomized, double-blind comparison with the phenothiazine perazine. Pharmacopsychiatry 20030101
Effects of cytochrome P-450 inducers on the perazine metabolism in a primary culture of human hepatocytes. Polish journal of pharmacology 20030101
The contribution of cytochrome P-450 isoenzymes to the metabolism of phenothiazine neuroleptics. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20021001
Switching to amisulpride due to hepatic complications. European psychiatry : the journal of the Association of European Psychiatrists 20020501
Perazine for schizophrenia. The Cochrane database of systematic reviews 20020101
Perazine as a potent inhibitor of human CYP1A2 but not CYP3A4. Polish journal of pharmacology 20020101
Intracellular distribution of psychotropic drugs in the grey and white matter of the brain: the role of lysosomal trapping. British journal of pharmacology 20011001
[Therapy of subclinical (subdiagnostic) syndromes of schizophrenia spectrum]. Fortschritte der Neurologie-Psychiatrie 20010901
Neuroleptics normalize increased release of interleukin- 1 beta and tumor necrosis factor-alpha from monocytes in schizophrenia. Schizophrenia research 20010701
Relevance of liver enzyme elevations with four different neuroleptics: a retrospective review of 7,263 treatment courses. Journal of clinical psychopharmacology 20010401
The effect of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics and metabolism of perazine in the rat. The Journal of pharmacy and pharmacology 20010401
[Obsessive-compulsive disorders in adolescents with diagnosed schizophrenia]. Psychiatria polska 20010101
[Neuroleptic malignant syndrome--case report]. Przeglad lekarski 20010101
Prevalence of obesity in adolescent and young adult patients with and without schizophrenia and in relationship to antipsychotic medication. Journal of psychiatric research 20010101
Effects of phenothiazine neuroleptics on the rate of caffeine demethylation and hydroxylation in the rat liver. Polish journal of pharmacology 20010101
Examination of iron (III) and hexacyanoferrate (III) ions as reagents for the spectrophotometric determination of promazine and perazine. Acta poloniae pharmaceutica 20010101
Cytochrome P-450 enzymes and FMO3 contribute to the disposition of the antipsychotic drug perazine in vitro. Psychopharmacology 20000901
An acute psychotic disorder caused by pefloxacin: a case report. Progress in neuro-psychopharmacology & biological psychiatry 19960201
[Psychotic episode caused by prevention of malaria with mefloquine. A case report]. Der Nervenarzt 19920501
[Electroconvulsive therapy in treatment of acute life threatening catatonia in toxic epidermal necrolysis (Lyell syndrome)]. Der Nervenarzt 19920501
Neurologic complications in patients treated with lithium. Psychiatric journal of the University of Ottawa : Revue de psychiatrie de l'Universite d'Ottawa 19880901
Properties